ʻOi aku ka nui me ka ulu ʻana o ka makahiki, ʻo nā comorbidities nā kumu pilikia i ke koho ʻana i nā ʻōlelo kuhikuhi a me nā kumu pilikia no ka prognosis o ka maʻi i ka wā o ka mālama ʻana. ʻO ka maʻi maʻi 2020 Covid-19 kekahi hōʻike o kēia. Nā wehewehe.

Ua wehewehe ʻia ka "Co-morbidity" e ka noho ʻana i ka manawa like i loko o ke kanaka hoʻokahi o nā maʻi maʻi mau e pono ai kēlā me kēia mālama mālama lōʻihi (Haute Autorité de santé HAS 2015 *). 

Hoʻopili pinepine ʻia kēia huaʻōlelo me ka wehewehe ʻana o ka "polypathology" e pili ana i ka mea maʻi e loaʻa ana i nā ʻano ʻano like ʻole e hopena i kahi kūlana pathological holoʻokoʻa e pono ai ka mālama mau. 

Ua wehewehe ʻo Social Security i ka huaʻōlelo "Long Term Affections" a i ʻole ALD no 100% ka uhi o ka mālama, aia he 30. 

Aia ma waena o lākou:

• mimikō;
• maʻi kūpale kolohe;
• nā maʻi cardiovascular ;
• HIV;
• hānō nui;
• nā maʻi psychiatric;
• etc.

Ua hōʻike ʻia kahi noiʻi Insee-Credes he 93% o ka poʻe i piha i ka makahiki 70 a ʻoi aʻe i loaʻa ma ka liʻiliʻi ʻelua maʻi i ka manawa like a me 85% ma kahi o ʻekolu.

ʻO ka loaʻa ʻana o nā co-morbidities e pili ana me ka polypharmacy (ka kuhikuhi ʻana o kekahi mau lāʻau lapaʻau i ka manawa like) hiki ke pilikia ma muli o nā pilina lāʻau. 

ʻOi aku ma mua o 10% o nā kānaka ma luna o 75 e lawe ma waena o 8 a me 10 mau lāʻau i kēlā me kēia lā. ʻO kēia ka mea maʻi pinepine me ka ALD a me ka poʻe ʻelemakule. 

Pono e hoʻomaopopo ʻia ʻo kekahi mau maʻi maʻi maʻi i hoʻokumu ʻia e ka poʻe ʻōpio e like me ka maʻi maʻi, nā maʻi psychiatric a i ʻole nā ​​​​maʻi maʻi maʻi. 

ʻO nā co-morbidities kekahi pilikia hou o ka hoʻopiʻi ʻana i ka wā o kahi maʻi koʻikoʻi e like me Covid-19 (SARS COV-2) a i ʻole ka maʻi maʻi kau. I ke alo o nā comorbidities, ʻoi aku ka maʻalahi o ke kino.

ʻO nā mea pili a me ka Coronavirus

ʻO ka loaʻa ʻana o nā co-morbidities he mea koʻikoʻi koʻikoʻi no ka hoʻopiʻi ʻana i ka wā maʻi me SARS COV-2 (COVID 19). ʻOiai ʻo ka makahiki he mea koʻikoʻi koʻikoʻi i loko ona iho, ʻo ka loaʻa ʻana o nā maʻi cardiovascular e like me ke hypertension, kahi mōʻaukala o ka puʻuwai a i ʻole ka hahau ʻana hiki ke alakaʻi i ka hopu ʻana i ka naʻau a i ʻole kahi hahau hou ma muli o nā kumuwaiwai e pono ai ke kino e hakakā i ka coronavirus. ʻO ka momona a i ʻole ka hanu ʻana he mau co-morbidities e hoʻonui ai i ka pilikia o nā hoʻopiʻi mai ka maʻi me SARS COV-2 (COVID 19).

ʻO nā maʻi maʻi a me ka maʻi kanesa

ʻO nā lāʻau lapaʻau chemotherapy i hoʻokō ʻia ma ke ʻano o ka mālama ʻana i ka maʻi maʻi e hoʻoikaika i ka hiki ʻana mai o nā thromboses (koko koko) i ke kahe koko ma muli o ke ʻano o ka mumū o ke kino holoʻokoʻa i hoʻopili ʻia i ke alo o ka ʻōpū. Hiki i kēia mau thromboses ke kumu o:

• phlebitis;
• hōʻeha puʻuwai;
• hahau ʻana;
• pulmonary embolism. 

ʻO ka mea hope loa, hiki i ka chemotherapy ke hoʻopilikia i ke kīkī (hoʻomaʻemaʻe koko) a me ka hana o ka ate a me ka hana ʻana o nā keʻokeʻo keʻokeʻo a me ka ʻulaʻula, hiki ke hoʻopilikia.

ʻO ka hana mua, ʻo ia ka hoʻonohonoho mua ʻana i nā lāʻau lapaʻau, ka nānā ʻana i nā lāʻau lapaʻau maikaʻi loa a pale aku i nā pilina lāʻau. ʻO kēia ke kuleana o ke kauka hele i ʻike pono i kona maʻi a me kāna hana ʻana i kēlā me kēia lapaʻau. Hoʻopaʻa pū ia i ka hoʻohui ʻana ma waena o nā mea kuleana like ʻole ma ka nīnau ʻana, inā pono, i kā lākou ʻōlelo aʻoaʻo a me kā lākou akamai. 

Pono nō hoʻi ka mālama ʻana i nā lāʻau lapaʻau maʻamau e hoʻololi i nā lāʻau lapaʻau i nā loli o nā maʻi a me ko lākou pōʻaiapili. Pono ke kauka hele e makaʻala i nā hopena psychosocial o kēia mau maʻi e like me ke kaumaha, ke kīnā a i ʻole ka maikaʻi ʻole o ke ola.